Biotech Values

[DewDiligence]

ACHN raised $50M in December via ATM with Cantor Fitzgerald (8-K filing today, but no PR):

http://www.sec.gov/Archives/edgar/data/1070336/000119312515007325/d850311d8k.htm

Between December 22, 2014 and December 31, 2014, Achillion Pharmaceuticals, Inc. sold shares of its common stock pursuant to the Sales Agreement, dated November 8, 2012, between the Company and Cantor Fitzgerald & Co., resulting in aggregate gross proceeds to the Company of $50 million. After giving effect to these sales, the Company estimates that its cash will be sufficient to meet its projected operating requirements into the fourth quarter of 2016.

ACHN clearly tried to hide this news amid the cornucopia of news flow from JPM. Sleazy.